Drug Therapy

  • GERD: A practical approach
    GERD: A practical approach
    Andrew Young, DO, Mythri Anil Kumar, MD and Prashanthi N. Thota, MD, FACG
    Cleveland Clinic Journal of Medicine April 2020, 87 (4) 223-230; DOI: https://doi.org/10.3949/ccjm.87a.19114

    PPIs are the first-line medical therapy. Endoscopic and surgical options are pursued only if medical therapy fails.

  • ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease
    Cara Reiter-Brennan, Albert D. Osei, MD, MPH, S. M. Iftekhar Uddin, MBBS, MSPH, Olusola A. Orimoloye, MD, MPH, Olufunmilayo H. Obisesan, MD, MPH, Mohammadhassan Mirbolouk, MD, Michael J. Blaha, MD, MPH and Omar Dzaye, MD, PhD
    Cleveland Clinic Journal of Medicine April 2020, 87 (4) 231-239; DOI: https://doi.org/10.3949/ccjm.87a.19078

    Risk assessment, drugs, patient subgroups, value of therapy, personalized plans, and shared decision-making.

  • A cough that won’t go away: Evaluation and treatment in 2 patients
    Maxwell Y. Lee, BS, Rachel M. Taliercio, DO, Michelle Adessa, MS, CCC-SLP, Claudio Milstein, PhD and Paul C. Bryson, MD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 83-89; DOI: https://doi.org/10.3949/ccjm.87a.19010

    Two patients present with similar symptoms, but different causes and treatment.

  • Type of diabetes mellitus: Does it matter to the clinician?
    Byron J. Hoogwerf, MD, FACP, FACE
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 100-108; DOI: https://doi.org/10.3949/ccjm.87a.19020

    Understanding the many faces of diabetes can make a difference in how clinicians select glucose-lowering therapy.

  • Familial hypercholesterolemia: Detect, treat, and ask about family
    Familial hypercholesterolemia: Detect, treat, and ask about family
    Nishant P. Shah, MD, Haitham M. Ahmed, MD, MPH and W. H. Wilson Tang, MD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 109-120; DOI: https://doi.org/10.3949/ccjm.87a.19021

    Patients can develop elevated LDL-C and atherosclerotic cardiovascular disease at a young age.

  • The search for precision
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 71-72; DOI: https://doi.org/10.3949/ccjm.87b.02020

    The day may come soon when we get EMR alerts if we try to prescribe certain drugs to patients with certain gene variants.

  • Correction
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 79;

    The article, “Fever in a traveler returning from Ethiopia,” by Ken Koon Wong, MD (Cleve Clin J Med 2020; 87(1):31–42; doi:10.3949/ccjm.87a.19017) contained an error in Table 7.

  • Pharmacogenomics: An evolving clinical tool for precision medicine
    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99; DOI: https://doi.org/10.3949/ccjm.87a.19073

    More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

  • In reply: How should diabetic dyslipidemia be treated?
    Ting-I Lee, MD, PhD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01004
  • How should diabetic dyslipidemia be treated?
    Taher Modarressi, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01003

Pages